04:33 PM EDT, 06/26/2024 (MT Newswires) -- Pushkal Garg, Chief Medical Officer and Executive Vice President of Development and Medical Affairs, on June 24, 2024, sold 2,103 shares in Alnylam Pharmaceuticals ( ALNY ) for $485,773. Following the Form 4 filing with the SEC, Garg has control over a total of 16,290 shares of the company, with 15,609 shares held directly and 681 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1178670/000173527624000069/xslF345X03/edgardoc.xml

Price: 244.43, Change: -0.74, Percent Change: -0.30